Publication | Closed Access

Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo

Cell-based Drug DeliveryNanomedicineDrug TargetingEngineeringPolymer-drug ConjugateMedicineBreast CancerTumor TargetingNano-drug DeliveryBiomedical EngineeringMatrix BiologyPharmacology